Disease Markers

Diagnostic and Prognostic Markers in Bladder Cancer


Status
Published

1Seoul National University Hospital, Seoul, Republic of Korea

2Chungbuk National University, Cheongju, Republic of Korea

3Baylor College of Medicine, Houston, USA

4University Hospital Hamburg-Eppendorf, Hamburg, Germany

5University Medical Center Hamburg-Eppendorf, Hamburg, Germany


Diagnostic and Prognostic Markers in Bladder Cancer

Description

Bladder cancer has the highest recurrence rate of any solid tumor. Due to the need for life-long surveillance, the perpatient cost of managing bladder cancer is among the highest for any cancer. In the context of relative limitations of the current standard of cystoscopy and cytology, there has been growing activity in the development of novel markers for bladder cancer detection. The ultimate goal of these novel markers would be to replace and/or complement cystoscopy as a sensitive and noninvasive surveillance tool. Standard prognostic features have limited ability to predict the outcome for bladder cancer patients. With recent advances in techniques, an extremely large number of new markers have been identified. New biomarkers that are predictive of outcomes would help clinicians provide the risk-stratification of patients and serve as prognostic indicators for individual patients.

Continuing identification of new markers in bladder cancer will enhance future diagnostic and therapeutic approaches to bladder cancer. We invite investigators to contribute original research articles as well as review articles that will stimulate continuing efforts to leverage biomarkers to improve diagnostic accuracy, discover the molecular pathophysiology underlying bladder cancer, develop strategies to treat these conditions, and evaluate the prognosis.

Potential topics include, but are not limited to:

  • Recent developments of diagnostic and prognostic biomarkers in bladder cancer
  • Advanced researches in diagnosis and surveillance of bladder cancer
  • The latest technologies for clinical evaluation and measuring outcomes with biomarkers

Articles

  • Special Issue
  • - Volume 2016
  • - Article ID 2425091
  • - Editorial

Diagnostic and Prognostic Markers in Bladder Cancer

Ja Hyeon Ku | Wun-Jae Kim | ... | Luis Alex Kluth
  • Special Issue
  • - Volume 2016
  • - Article ID 5259602
  • - Review Article

Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis

Xiaoning Gan | Xiaomiao Lin | ... | Gang Chen
  • Special Issue
  • - Volume 2016
  • - Article ID 8463731
  • - Research Article

HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder

Bohyun Kim | Gilhyang Kim | ... | Kyung Chul Moon
  • Special Issue
  • - Volume 2016
  • - Article ID 4149608
  • - Research Article

Network Biomarkers of Bladder Cancer Based on a Genome-Wide Genetic and Epigenetic Network Derived from Next-Generation Sequencing Data

Cheng-Wei Li | Bor-Sen Chen
  • Special Issue
  • - Volume 2016
  • - Article ID 8205836
  • - Review Article

Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes

Masayoshi Nagata | Satoru Muto | Shigeo Horie
  • Special Issue
  • - Volume 2016
  • - Article ID 7276502
  • - Research Article

Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker

Sunga Choi | Ju Hyun Shin | ... | Byeong Hwa Jeon
  • Special Issue
  • - Volume 2016
  • - Article ID 8345286
  • - Review Article

Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder Cancer

Hyung Suk Kim | Ja Hyeon Ku
  • Special Issue
  • - Volume 2015
  • - Article ID 383509
  • - Research Article

Correlation and Significance of Urinary Soluble Fas and Vascular Endothelial Growth Factor in Bladder Urothelial Cancer

Huixiang Yang | Zhiyong Wang | ... | Zemin Wang
  • Special Issue
  • - Volume 2015
  • - Article ID 840640
  • - Review Article

Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor

Hiroki Ide | Hiroshi Miyamoto
  • Special Issue
  • - Volume 2015
  • - Article ID 857416
  • - Review Article

Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy

Yasuyoshi Miyata | Hideki Sakai
Disease Markers
 Journal metrics
Acceptance rate34%
Submission to final decision88 days
Acceptance to publication43 days
CiteScore3.500
Impact Factor2.738
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.